ResearcherNanjing University of Chinese MedicineNo recent work listed

Mingming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8158-2879; OpenAlex author ID A5026191548. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

A New C22-Quassinoid with Anti-Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. Co-author DOI 10.1002/cbdv.202101004 ↗
Glycoproteomic Bioanalysis of Exosomes by LC–MS for Early Diagnosis of Pancreatic Cancer Co-author DOI 10.4155/bio-2021-0036 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cheng‐Bin Yang · 1 shared paper, 2022 · strength 0.16
- Paper A New C22-Quassinoid with Anti-Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. DOI 10.1002/cbdv.202101004 ↗
Ming Zhao · 1 shared paper, 2022 · strength 0.16
- Paper A New C22-Quassinoid with Anti-Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. DOI 10.1002/cbdv.202101004 ↗
Si‐Nan Lu · 1 shared paper, 2022 · strength 0.16
- Paper A New C22-Quassinoid with Anti-Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. DOI 10.1002/cbdv.202101004 ↗
Jun Xia · 1 shared paper, 2021 · strength 0.15
- Paper Glycoproteomic Bioanalysis of Exosomes by LC–MS for Early Diagnosis of Pancreatic Cancer DOI 10.4155/bio-2021-0036 ↗
Shuang Yang · 1 shared paper, 2021 · strength 0.15
- Paper Glycoproteomic Bioanalysis of Exosomes by LC–MS for Early Diagnosis of Pancreatic Cancer DOI 10.4155/bio-2021-0036 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.